WHO suspends research on'hydroxychloroquine 'which was expected as a new corona treatment

It was discovered that the World Health Organization (WHO) will suspend clinical trials of hydroxychloroquine , which was expected to be a therapeutic drug for novel coronavirus infection (COVID-19). The decision appears to be in response to a global study showing that people taking hydroxychloroquine are at increased risk of death and heart disease.

WHO Director-General's opening remarks at the media briefing on COVID-19-25 May 2020
https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---25-may-2020

WHO halts hydroxychloroquine trial for coronavirus amid safety fears | World news | The Guardian
https://www.theguardian.com/world/2020/may/25/who-world-health-organization-hydroxychloroquine-trial-trump-coronavirus-safety-fears

Coronavirus: WHO pauses trial of hydroxychloroquine amid safety concerns
https://www.cnbc.com/2020/05/25/coronavirus-whos-solidarity-trial-is-pausing-tests-for-hydroxychloroquine-amid-safety-concerns.html

Hydroxychloroquine, which has been used in the United States as an antimalarial drug since the mid-1950s, attracted attention because President Trump said that it may be a game changer of COVID-19 on March 19, 2020. It was. After that, in the United States, an emergency use license was issued for hydroxychloroquine and chloroquine phosphate, but in a peer-reviewed paper published on May 22, 2020, hydroxychloroquine significantly increased the risk of death and cardiac arrhythmia among hospitalized patients. It has been shown to increase.

Survey results that the new corona drug increased the risk of death and heart disease in hospitalized patients-GIGAZINE

At a WHO press conference following the publication of the paper, WHO Executive Secretary Tedros Adanom announced that due to safety concerns, research on hydroxychloroquine as a COVID-19 therapeutic agent was suspended. According to Tedros, the clinical trial of hydroxychloroquine involving WHO at the time of writing the article is under review by an independent executive body.

'This review will collect data from WHO's previous joint studies, certain randomized controlled trials, and evaluate the potential benefits and risks of this drug. While being evaluated, the independent enforcement agency has temporarily suspended testing for hydroxychloroquine. '

'The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board'- @DrTedros # COVID19

— World Health Organization (WHO) (@WHO) May 25, 2020

“This concern is related to the administration of hydroxychloroquine and chloroquine to COVID-19 patients. The use of drugs for autoimmune diseases and malaria remains common,” said Tedros. I would like to reiterate what is recognized as safe by the company. '

On May 18, President Trump revealed that he was taking hydroxychloroquine daily for a week and a half. Although President Trump is not infected with the new coronavirus, he received a letter from a person who responded to the infectious disease at the forefront, saying that he was taking hydroxychloroquine prophylactically, and started taking it. That. When asked by a reporter, 'Are the White House doctors recommended?', President Trump replied, 'Ask your doctor.'